SCI时时刷

search
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause
The study objective was to estimate all-cause healthcare resource utilization (HCRU) and medical and pharmacy costs for wo...
Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor
Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor
People with type 2 diabetes (T2D) have a higher risk of stroke and worse outcomes than those without T2D. Pooled ...
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis
Major depressive disorder (MDD) is a debilitating and costly condition. This analysis characterized the health-related qua...
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
Vibegron is a β3-adrenergic receptor agonist approved for overactive bladder (OAB). This analysis assessed real-world...
Perceptions and Experiences of People with Obesity and Type 2 Diabetes Around Appetite and Eating Behaviors: A Qualitative Study
Perceptions and Experiences of People with Obesity and Type 2 Diabetes Around Appetite and Eating Behaviors: A Qualitative Study
Chronic weight management and treatments for type 2 diabetes (T2D) involve a combination of lifestyle-based (diet, exercis...
‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar
‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar
Hyrimoz®, (GP2017 [SDZ-ADL]), is a biosimilar to Humira® (REF-ADL). SDZ-ADL was approved in 2018 by both the Uni...
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review
Adalimumab (ADL, Humira®, reference product), an anti-TNF-α biologic, has transformed the treatment of chronic, ...
A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers
A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers
There is an urgent unmet medical need for a safe, effective, nonopioid analgesic agent for postoperative pain control. Thi...
The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson’s Disease
The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson’s Disease
Ethnicity differences are an important determinant in the clinical manifestation of Parkinson’s disease (PD), but th...
The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey
The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey
The coronavirus disease 2019 (COVID-19) pandemic created challenges related to disease management of patients with ulcerat...
Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer: A Case-Series Study
Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer: A Case-Series Study
Antibody–drug conjugate (ADC) and programmed death-1 (PD-1) inhibitors play crucial roles in the treatment of advanc...
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
In the event-driven FREEDOM-EV trial, oral treprostinil delayed clinical worsening in patients with pulmonary arterial hyp...
Burden of Disease and Productivity Loss in the European Economic Area in Patients Affected by Fibrosing Interstitial Lung Disease
Burden of Disease and Productivity Loss in the European Economic Area in Patients Affected by Fibrosing Interstitial Lung Disease
Progression of fibrosis in interstitial lung diseases (ILD) has been associated with poor prognosis, lower quality of life...
Nationwide Study of Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Urothelial Carcinoma in Hungary
Nationwide Study of Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Urothelial Carcinoma in Hungary
Data describing real-world treatment patterns in patients with metastatic urothelial carcinoma (mUC) in Central-Eastern Eu...